Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 22;194(32):E1113-E1116.
doi: 10.1503/cmaj.220324.

Pharmaceutical security for Canada

Shoo K Lee  1 , Sukhy K Mahl  2 , Brian H Rowe  2 , Joel Lexchin  2
Affiliations

Pharmaceutical security for Canada

Shoo K Lee et al. CMAJ. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: Sukhy Mahl reports receiving organizational support from the Maternal-Infant Care Research Centre (MiCare) at Mount Sinai Hospital in Toronto, Ontario, Canada. MiCare is supported by a Canadian Institutes of Health Research (CIHR) Team Grant (CTP 87518) and the Ontario Ministry of Health. Joel Lexchin reports receiving royalties from the University of Toronto Press and James Lorimer & Co. Ltd. for books he has written. Dr. Lexchin has also received payments from the CIHR and payment for expert testimony from Goodmans LLP. He is a member of the Foundation Board of Health Action International and the Board of Canadian Doctors for Medicare. Brian Rowe’s research is supported by a Scientific Directors Operating Grant (SOP 168483) from CIHR. Dr. Rowe is the Scientific Director of the Institute of Circulatory and Respiratory Health, CIHR, and Professor and Director at the Emergency Medicine Research Group, Department of Emergency Medicine, Faculty of Medicine and Dentistry, College of Health Sciences. Shoo Lee reports receiving grant support for the MiCare team from CIHR. Dr. Lee is also the president of the Canadian Neonatal Foundation (a charity).

References

    1. The Critical Drug Reserve during COVID-19. Ottawa: Government of Canada; 2021. Available: https://www.canada.ca/en/health-canada/services/drugs-health-products/co... (accessed 2022 Jan. 27).
    1. Zhang W, Guh DP, Sun H, et al. . Factors associated with drug shortages in Canada: a retrospective cohort study. CMAJ Open 2020;8:E544–E. - PMC - PubMed
    1. Pharmaceutical industry profile. Ottawa: Government of Canada; modified 2021 Aug. 4. Available: https://www.ic.gc.ca/eic/site/lsg-pdsv.nsf/eng/h_hn01703.html (accessed 2021 Apr. 20).
    1. Koronios E. Brand-name pharmaceutical manufacturing in Canada: industry Report 32541ACA. IBISWorld.com; 2020.
    1. DellaCamera C. Generic pharmaceutical manufacturing in Canada: industry report 32541BCA. IBISWorld.com; 2021.

Substances